In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series B generates $20mm for Carticept Medical

Executive Summary

Carticept Medical (devices for cartilage repair and osteoarthritis) raised $20mm in its Series B round to first-time backer and ultrasound specialist SonoSite and returning Series A participants Domain Associates and New Enterprise Associates. The company will use the funds to launch its Navigator medication delivery system, and for clinical development of the Cartiva synthetic cartilage implant.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register